Dr. Aron Schwarcz is Board Certified in Cardiovascular Disease, Echocardiography, Nuclear Cardiology, Internal Medicine and Interventional Cardiology. He completed his Internal Medicine residency, as well as his Cardiology and Interventional Cardiology Fellowships at Montefiore Medical Center. In 2013, he was inducted into the Leo M. Davidoff society of the Albert Einstein College of Medicine for outstanding achievement in the teaching of medical students.

Dr. Schwarcz joined Cardiovascular Associates of North Jersey in 2013 as the Interventional Cardiologist of the group. Most of his procedures are performed at the cath lab at Englewood Hospital and Medical Center. There he is involved in many committees including the Coronary Artery Disease Subcommittee and he chairs the STEMI Door to Balloon Committee. He is co-director of the Coronary Chronic Total Occlusion (CTO) program, which he helped establish in 2015. He has also been the Primary Investigator for a number of nationwide clinical research studies at Englewood Hospital and Medical Center including ones on the use of antiplatelets after Percutaneous Coronary Interventions (PCI). He is also part of the Transcatheter Aortic Valve Replacement (TAVR) team at Englewood Hospital.

His areas of interest are coronary artery disease, acute coronary syndromes, high risk and complex percutaneous coronary interventions including chronic total occlusions, adjunctive tools during cardiac catheterizations and cardiovascular research.

While he is passionate about his work in the cath lab, he feels it is essential to take the time to explain and discuss the care plan with the patient and their family. Communication and education is critical to get the best outcome with the patient.